Ontology highlight
ABSTRACT:
SUBMITTER: Kastritis E
PROVIDER: S-EPMC5520394 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Kastritis E E Gavriatopoulou M M Roussou M M Fotiou D D Ziogas D C DC Migkou M M Eleutherakis-Papaiakovou E E Panagiotidis I I Kanellias N N Psimenou E E Papadopoulou E E Pamboucas C C Manios E E Gakiopoulou H H Ntalianis A A Tasidou A A Giannouli S S Terpos E E Dimopoulos M A MA
Blood cancer journal 20170616 6
Bortezomib, in combination with dexamethasone (VD) or with the addition of cyclophosphamide (VCD), is highly effective in patients with amyloid light-chain (AL) amyloidosis. Currently, VCD is considered as a primary regimen for patients with AL, but it is not clear whether the addition of cyclophosphamide to VD further and significantly improves efficacy, given the substantial activity of bortezomib itself. We retrospectively compared the outcomes of 101 patients with AL amyloidosis who received ...[more]